29 Oct 2022

Dr Dave Michalovich
SVP Precision Medicine

Join Dr Dave Michalovich, SVP Precision Medicine, for an online talk on integrated AI/ML and omics approaches for GBM drug discovery.

Dave will be speaking at the Glioma Update: The Molecular Era, a meeting hosted by the National University Hospital Singapore. In his talk, he will give an overview of the Benevolent Platform™ and our precision medicine workflows, and present our approach to hypothesis generation and target validation in GBM.

Register for this event

Dr Dave Michalovich

Dave is responsible for driving the Precision Medicine strategy at BenevolentAI, taking a patient-centric approach to understand disease endotypes, mechanisms and targets. Prior to joining BenevolentAI Dave was a Senior Scientific Director at GSK where he led discovery teams in the Adaptive Immunity Research Unit and Respiratory TA.

Back to events